Thanks to @pubs.acs.org for accepting #MyACSCover featuring our work.

Siponimod (red) binds strongly to both sphingosine-1-phosphate (S1P) receptor 1 (green, active) and receptor 2 (blue, inactive), but only S1PR1 undergoes the conformational changes needed for activation.

Hearty congratulations to the authors, Soniya, Kruthika, Chanukya and Antarip

pubs.acs.org/doi/10.1021/...

⛏️ Understanding how drugs modulate targets is increasingly as important as which targets they hit. This isn’t easy to figure out and deep science and deep tech are evolving fast to help find the answers.

www.aganitha.ai/blogs/uneart...

🏛️ Regulators are also signaling change. With the
@US_FDA articulating “plausible mechanism” pathways where RCTs are limited, mechanistic clarity is becoming an evidentiary asset, not a luxury.

www.nejm.org/doi/full/10....

📈 This matters now more than ever. #GPCRs dominate today’s biggest therapeutic wins, most visibly in obesity, where how receptors are modulated drives both efficacy and tolerability.

link.springer.com/article/10.1...

⚙️ Using long-timescale molecular dynamics (#MD), ensemble analysis & #GPCR transmission-switch reasoning, we explain a clinically relevant selectivity and safety phenotype.

Learn more about Aganitha solutions for #ConsumerCare R&D at www.aganitha.ai/solutions-fo...

#AI #CompChem #MultiOmics #AI4Science #Sustainability

🛠️ Aganitha AI solutions for #ConsumerCare R&D acceleration:

🧪 Surfactant discovery & optimization
⚖️ Stability profiling under real-world conditions
🧍‍♀️ Skin sensitization modeling
🌿 Biopolymer design
🦠 Microbiome analysis

Major paradigm shifts in #ConsumerCare:

🌱 Petroleum based → natural & bio-polymer
🐇 Animal testing → in silico models
🧴 Harsh chemicals → probiotics & enzymes

Aganitha accelerates this transformation through simulations, predictions, optimizations & safety models 🚀

DISTILL™ is built from the ground up for the #LLM & #AgenticAI era. Every capability is accessible via #MCP — enabling faster, more impactful progress across disease research, target & biomarker discovery, patient stratification, & indication expansion.

#scRNAseq #RNAseq #Omics

At Aganitha, we make #AI work for science. DISTILL™ is our #SingleCell #Omics analysis platform, built to accelerate the decoding of complex biology across public and private studies — spanning species, disease contexts, and interventions.

But, what if the best place in the world to tackle KJ’s sickness wasn’t next door? Can we work towards a world where for every kid born like KJ with rare genetic disorders, treatments can be custom designed if necessary? Can #AI help widen access?

www.aganitha.ai/blogs/person...

KJ became first patient in the world to be treated with a personalised gene therapy that was custom-designed and tested for his specific genetic variation, within just a few months.

youtu.be/mUQWWLErLaY?...

Want to know more? Visit us at www.aganitha.ai

🎯 Watch the demo

See # Igniva in action and imagine what agent-powered science could enable in your R&D workflows.

🚀 What this unlocks

With tools like #Igniva, researchers can:

Spend less time wrangling data

Focus more on hypothesis generation

Combine cross-domain insights faster than ever before